Soliton found using ticker (SOLY) now have 3 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The range between the high target price and low target price is between 22 and 12 and has a mean target at 16. With the stocks previous close at 8.37 this is indicating there is a potential upside of 91.2%. The day 50 moving average is 8.4 and the 200 day moving average is 8.22. The market capitalisation for the company is $177m. You can visit the company’s website by visiting: http://www.soliton.com
Soliton, a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers product for the removal of tattoos. It also develops product for cellulite reduction, fibrotic scar treatment, and other indications. The company was founded in 2012 and is based in Houston, Texas.